IceCure Medical Ltd. Files July 2025 Meeting Notice
Ticker: ICCM · Form: 6-K · Filed: Jul 28, 2025 · CIK: 1584371
Sentiment: neutral
Topics: filing, corporate-governance, meeting-notice
Related Tickers: ICUR
TL;DR
ICUR filed a 6-K for July meeting notice & proxy statement.
AI Summary
IceCure Medical Ltd. filed a Form 6-K on July 28, 2025, to report its Notice of Meeting and Proxy Statement for the month of July 2025. The filing is from their principal executive offices in Caesarea, Israel.
Why It Matters
This filing provides shareholders with essential information regarding upcoming meetings and voting procedures, impacting corporate governance and decision-making.
Risk Assessment
Risk Level: low — This is a routine administrative filing providing notice of a meeting and proxy information, not indicating new financial or operational risks.
Key Players & Entities
- IceCure Medical Ltd. (company) — Registrant
- July 2025 (date) — Reporting period for the 6-K
- Caesarea, Israel (location) — Principal executive offices
FAQ
What type of report is IceCure Medical Ltd. filing?
IceCure Medical Ltd. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What is the filing date of this report?
This report was filed as of July 28, 2025.
Where are IceCure Medical Ltd.'s principal executive offices located?
The principal executive offices are located at 7 Ha'Eshel St., PO Box 3163, Caesarea, 3079504, Israel.
What is the purpose of this Form 6-K filing?
The purpose of this filing is to report the Registrant's Notice of Meeting and Proxy Statement for the month of July 2025.
Does IceCure Medical Ltd. file annual reports under Form 20-F or 40-F?
Yes, IceCure Medical Ltd. files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 28, 2025 regarding IceCure Medical Ltd. (ICCM).